We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Committee Review of Heart Risk Due to Testosterone Products Inconclusive
EMA Committee Review of Heart Risk Due to Testosterone Products Inconclusive
A key European health committee didn’t find enough evidence to confirm that testosterone-replacement (TRT) products create higher heart attack risk, but it did agree with FDA advisors that labeling for such products should change.